Back to Search
Start Over
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
- Source :
- Targeted Oncology. 18:269-285
- Publication Year :
- 2023
- Publisher :
- Springer Science and Business Media LLC, 2023.
- Subjects :
- Cancer Research
Oncology
Pharmacology (medical)
Subjects
Details
- ISSN :
- 1776260X and 17762596
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Targeted Oncology
- Accession number :
- edsair.doi...........b83a4b5ffa700d6591f630c62f30ad00